281 related articles for article (PubMed ID: 32306849)
1. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
2. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
Miyagawa I; Tanaka Y
Expert Rev Clin Immunol; 2020 Feb; 16(2):199-206. PubMed ID: 31905298
[No Abstract] [Full Text] [Related]
3. Optimal Biologic Selection for Treatment of Psoriatic Arthritis: the Approach to Precision Medicine.
Miyagawa I; Nakayamada S; Tanaka Y
Curr Rheumatol Rep; 2019 Mar; 21(5):21. PubMed ID: 30891646
[TBL] [Abstract][Full Text] [Related]
4. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis.
Miyagawa I; Nakayamada S; Nakano K; Kubo S; Iwata S; Miyazaki Y; Yoshikawa M; Yoshinari H; Tanaka Y
Rheumatology (Oxford); 2019 Feb; 58(2):336-344. PubMed ID: 29618121
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases
Tanaka Y; Kubo S; Miyagawa I; Iwata S; Nakayamada S
Semin Arthritis Rheum; 2019 Jun; 48(6):1146-1150. PubMed ID: 31079846
[TBL] [Abstract][Full Text] [Related]
7. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.
Lie E; Fagerli KM; Mikkelsen K; Rødevand E; Lexberg A; Kalstad S; Uhlig T; Kvien TK
Ann Rheum Dis; 2014 Oct; 73(10):1905-6. PubMed ID: 24989896
[No Abstract] [Full Text] [Related]
8. An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis.
So A; Inman RD
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):453-471. PubMed ID: 31171315
[TBL] [Abstract][Full Text] [Related]
9. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
Simone D; Nowik M; Gremese E; Ferraccioli GF
J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
[TBL] [Abstract][Full Text] [Related]
10. Updated guidelines for the management of axial disease in psoriatic arthritis.
Nash P; Lubrano E; Cauli A; Taylor WJ; Olivieri I; Gladman DD
J Rheumatol; 2014 Nov; 41(11):2286-9. PubMed ID: 25362712
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
[TBL] [Abstract][Full Text] [Related]
12. The road to personalised medicine in psoriatic arthritis.
White JPE; Coates LC
Expert Rev Clin Immunol; 2021 Aug; 17(8):799-802. PubMed ID: 34000952
[No Abstract] [Full Text] [Related]
13. Treatment strategies for psoriatic arthritis.
Schemoul J; Poulain C; Claudepierre P
Joint Bone Spine; 2018 Oct; 85(5):537-544. PubMed ID: 29155104
[TBL] [Abstract][Full Text] [Related]
14. Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Ooms A; Al-Mossawi H; Bennett L; Bogale M; Bowness P; Francis A; Goodyear C; Kirkham BW; Lalnunhlimi S; McInnes IB; Richards D; Siebert S; Taams LS; Tulunay Virlan A; Yager N; Coates LC
BMJ Open; 2023 Sep; 13(9):e078539. PubMed ID: 37770264
[TBL] [Abstract][Full Text] [Related]
15. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis.
Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH
Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?
Elalouf O; Chandran V
Curr Rheumatol Rep; 2018 May; 20(7):36. PubMed ID: 29846825
[TBL] [Abstract][Full Text] [Related]
17. Therapy strategies in psoriatic arthritis.
Coates LC
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S70-2. PubMed ID: 26470949
[TBL] [Abstract][Full Text] [Related]
18. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy.
Raghunath S; Hijjawi R; Hoon E; Shanahan EM; Goldblatt F
Clin Rheumatol; 2019 Oct; 38(10):2699-2707. PubMed ID: 31172365
[TBL] [Abstract][Full Text] [Related]
19. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
20. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
Stiff KM; Glines KR; Porter CL; Cline A; Feldman SR
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1209-1218. PubMed ID: 30449211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
